Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer.

Liu HB, Gu XL, Ma XQ, Lv TF, Wu Y, Xiao YY, Yuan DM, Li YF, Song Y.

Neoplasma. 2013;60(2):203-8.

PMID:
23259790
2.

Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer.

Zhang J, Huang SH, Li H, Li Y, Chen XL, Zhang WQ, Chen HG, Gu LJ.

Med Oncol. 2013 Mar;30(1):352. doi: 10.1007/s12032-012-0352-3. Epub 2012 Dec 30.

PMID:
23275140
3.

[Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].

Li Y, Wei S, Wang J, Hong L, Cui L, Wang C.

Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):789-96. doi: 10.3779/j.issn.1009-3419.2014.11.04. Chinese.

4.

[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].

Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.

Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. German.

PMID:
17109272
5.

Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).

Ma Q, Liu D, Guo Y, Shi B, Song Z, Tian Y.

Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):342-8. doi: 10.3779/j.issn.1009-3419.2010.04.14.

6.

[Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].

Li Y, Sun BS, Zhang ZF, Zhang LM, Wang CL.

Zhonghua Yi Xue Za Zhi. 2011 Jun 28;91(24):1682-6. Chinese.

PMID:
21914316
7.

Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.

Wang CL, Li Y, Yue DS, Zhang LM, Zhang ZF, Sun BS.

World J Surg. 2012 Feb;36(2):455-62. doi: 10.1007/s00268-011-1360-8.

PMID:
22187129
8.

Impact of main bronchial lymph node involvement in pathological T1-2N1M0 non-small-cell lung cancer: multi-institutional survey by the Japan National Hospital Study Group for Lung Cancer.

Maeda H, Fukai S, Matsumura A, Kawashima O, Watanabe T, Yamanda T, Okabayashi K, Fujita Y, Tamura A, Kawahara M.

Gen Thorac Cardiovasc Surg. 2009 Nov;57(11):599-604. doi: 10.1007/s11748-009-0451-z. Epub 2009 Nov 12.

PMID:
19908114
9.

Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.

Demir A, Turna A, Kocaturk C, Gunluoglu MZ, Aydogmus U, Urer N, Bedirhan MA, Gurses A, Dincer SI.

Ann Thorac Surg. 2009 Apr;87(4):1014-22. doi: 10.1016/j.athoracsur.2008.12.053.

PMID:
19324121
10.

Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer.

Kobayashi N, Usui S, Kikuchi S, Goto Y, Sakai M, Onizuka M, Sato Y.

Lung Cancer. 2012 Feb;75(2):223-7. doi: 10.1016/j.lungcan.2011.06.009. Epub 2011 Jul 20.

PMID:
21764477
11.

Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.

Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.

Ann Thorac Surg. 2006 Jan;81(1):292-7.

PMID:
16368383
12.

A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.

Shi CL, Zhang XY, Han BH, He WZ, Shen J, Chu TQ.

Med Oncol. 2011 Dec;28(4):1441-6. doi: 10.1007/s12032-010-9632-y. Epub 2010 Jul 27.

PMID:
20661664
13.

[Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].

Zhang GQ, Han F, Gao SL, A DL, Pang ZL.

Ai Zheng. 2007 May;26(5):519-23. Chinese.

PMID:
17672944
14.

Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients.

Ji Y, Sheng L, Du X, Qiu G, Su D.

Platelets. 2015;26(2):138-42. doi: 10.3109/09537104.2014.888547. Epub 2014 Mar 28.

PMID:
24679181
15.

The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.

Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, Kucharczuk JC, Lin L, Rengan R.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):340-7. doi: 10.1016/j.ijrobp.2011.05.070. Epub 2011 Nov 19.

PMID:
22104359
16.

Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?

Kudo Y, Saji H, Shimada Y, Nomura M, Usuda J, Kajiwara N, Ohira T, Ikeda N.

Eur J Cardiothorac Surg. 2012 Sep;42(3):414-9. doi: 10.1093/ejcts/ezs065. Epub 2012 Mar 6.

PMID:
22398463
17.

Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.

Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, Schneider PM, Hölscher AH.

J Surg Oncol. 2003 Apr;82(4):256-60.

PMID:
12672010
18.

Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer.

Osaki T, Nagashima A, Yoshimatsu T, Tashima Y, Yasumoto K.

Lung Cancer. 2004 Feb;43(2):151-7.

PMID:
14739035
19.

Prognostic significance of thrombocytosis in patients with primary lung cancer.

Pedersen LM, Milman N.

Eur Respir J. 1996 Sep;9(9):1826-30.

20.

Supplemental Content

Support Center